Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice

Anesthesiology

Volumn 115, Issue 4, 2011, Pages 804-811

  Petersen, Bodil ^a,b   Austen, K Frank ^a   Bloch, Kenneth D ^a   Hotta, Yukako ^a   Ichinose, Fumito ^a   Kanaoka, Yoshihide ^a   Zapol, Warren M ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c William Thomas Green Morton Department of Anesthesia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYL LEUKOTRIENE RECEPTOR 1; ENDOTOXIN; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR; MYELOPEROXIDASE; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; HYPOXIC LUNG VASOCONSTRICTION; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG LAVAGE; LUNG VASCULAR RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

EID: 80053373071     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31822e94bd     Document Type: Article

References (47)

1. Thomas HM 3rd, Garrett RC: Strength of hypoxic vasoconstriction determines shunt fraction in dogs with atelectasis. J Appl Physiol 1982; 53:44-51 (Pubitemid 12092408)
2. Brimioulle S, LeJeune P, Naeije R: Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J Appl Physiol 1996; 81:1535-43 (Pubitemid 26349604)
3. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG: Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979; 120:1039-52 (Pubitemid 10218491)
4. Sharma S, Kumar A: Septic shock, multiple organ failure, and acute respiratory distress syndrome. Curr Opin Pulm Med 2003; 9:199-209 (Pubitemid 36432895)
5. Weir EK, Mlczoch J, Reeves JT, Grover RF: Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med 1976; 88:975-83 (Pubitemid 8002489)
6. Hales CA, Sonne L, Peterson M, Kong D, Miller M, Watkins WD: Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 1981; 68:497-505 (Pubitemid 11039631)
7. Chang SW, Feddersen CO, Henson PM, Voelkel NF: Plateletactivating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987; 79: 1498-509 (Pubitemid 17099656)
8. Theissen JL, Loick HM, Curry BB, Traber LD, Herndon DN, Traber DL: Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J Appl Physiol 1991; 70:2120-5
9. Ullrich R, Bloch KD, Ichinose F, Steudel W, Zapol WM: Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J Clin Invest 1999; 104:1421-9
10. Ichinose F, Zapol WM, Sapirstein A, Ullrich R, Tager AM, Coggins K, Jones R, Bloch KD: Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res 2001; 88:832-8 (Pubitemid 32429980)
11. Baboolal HA, Ichinose F, Ullrich R, Kawai N, Bloch KD, Zapol WM: Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice. ANESTHESIOLOGY 2002; 97:1227-33 (Pubitemid 35265578)
12. Spohr F, Busch CJ, Teschendorf P, Weimann J: Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic mice. J Physiol Pharmacol 2009; 60:107-12
13. Paky A, Michael JR, Burke-Wolin TM, Wolin MS, Gurtner GH: Endogenous production of superoxide by rabbit lungs: Effects of hypoxia or metabolic inhibitors. J Appl Physiol 1993; 74:2868-74 (Pubitemid 23201317)
14. Marshall C, Mamary AJ, Verhoeven AJ, Marshall BE: Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol 1996; 15:633-44 (Pubitemid 126440603)
15. Waypa GB, Chandel NS, Schumacker PT: Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 2001; 88:1259-66 (Pubitemid 32587842)
16. Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R, Archer SL: Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 2002; 90:1307-15 (Pubitemid 34787413)
17. Stevens T, Morris K, McMurtry IF, Zamora M, Tucker A: Pulmonary and systemic vascular responsiveness to TNFalpha in conscious rats. J Appl Physiol 1993; 74:1905-10 (Pubitemid 23133492)
18. Rouzer CA, Matsumoto T, Samuelsson B: Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 1986; 83:857-61 (Pubitemid 16086376)
19. Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK: Requirement of a 5-lipoxygenaseactivating protein for leukotriene synthesis. Nature 1990; 343:282-4
20. Evans JF, Dupuis P, Ford-Hutchinson AW: Purification and characterisation of leukotriene A4 hydrolase from rat neutrophils. Biochim Biophys Acta 1985; 840:43-50 (Pubitemid 15042013)
21. Nicholson DW, Ali A, Vaillancourt JP, Calaycay JR, Mumford RA, Zamboni RJ, Ford-Hutchinson AW: Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: A homodimeric glutathione S-transferase composed of 18-kDa subunits. Proc Natl Acad Sci USA 1993; 90:2015-9 (Pubitemid 23069988)
22. Lam BK, Penrose JF, Freeman GJ, Austen KF: Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci USA 1994; 91:7663-7 (Pubitemid 24238245)
23. Welsch DJ, Creely DP, Hauser SD, Mathis KJ, Krivi GG, Isakson PC: Molecular cloning and expression of human leukotriene-C4 synthase. Proc Natl Acad Sci USA 1994; 91:9745-9 (Pubitemid 24311884)
24. Carter BZ, Shi ZZ, Barrios R, Lieberman MW: Gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen. J Biol Chem 1998; 273:28277-85 (Pubitemid 28496127)
25. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams DL Jr, Ford-Hutchinson AW, Caskey CT, Evans JF: Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399:789-93 (Pubitemid 29293175)
26. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL Jr, Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF: Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000; 275:30531-6
27. Maekawa A, Kanaoka Y, Xing W, Austen KF: Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci USA 2008; 105:16695-700
28. Paruchuri S, Jiang Y, Feng C, Francis SA, Plutzky J, Boyce JA: Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J Biol Chem 2008; 283:16477-87
29. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T: A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997; 387:620-4 (Pubitemid 27248768)
30. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T: A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 2000; 192:421-32
31. Lewis RA, Austen KF: The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest 1984; 73:889-97 (Pubitemid 14132816)
32. Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323:645-55 (Pubitemid 20280195)
33. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967; 2:319-23
34. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-49 (Pubitemid 30408719)
35. Stephenson AH, Lonigro AJ, Hyers TM, Webster RO, Fowler AA: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988; 138:714-9
36. Baenkler M, Leykauf M, John S: Functional analysis of eicosanoids from white blood cells in sepsis and SIRS. J Physiol Pharmacol 2006; 57(Suppl 12):25-33 (Pubitemid 46569826)
37. Mamedova L, Capra V, Accomazzo MR, Gao ZG, Ferrario S, Fumagalli M, Abbracchio MP, Rovati GE, Jacobson KA: CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol 2005; 71:115-25 (Pubitemid 41713533)
38. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S: Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 2006; 103:16394-9 (Pubitemid 44715207)
39. Kanaoka Y, Maekawa A, Penrose JF, Austen KF, Lam BK: Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J Biol Chem 2001; 276:22608-13
40. Maekawa A, Austen KF, Kanaoka Y: Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 2002; 277: 20820-4 (Pubitemid 34967388)
41. Ichinose F, Ullrich R, Sapirstein A, Jones RC, Bonventre JV, Serhan CN, Bloch KD, Zapol WM: Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. J Clin Invest 2002; 109:1493-500 (Pubitemid 34596175)
42. Hellman J, Roberts JD Jr, Tehan MM, Allaire JE, Warren HS: Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice. J Biol Chem 2002; 277: 14274-80 (Pubitemid 34968042)
43. Ortiz JL, Gorenne I, Cortijo J, Seller A, Labat C, Sarria B, Abram TS, Gardiner PJ, Morcillo E, Brink C: Leukotriene receptors on human pulmonary vascular endothelium. Br J Pharmacol 1995; 115:1382-6
44. Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y, Kanaoka Y, Conley P, Boyce JA: Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 2009; 206:2543-55
45. Lärfars G, Lantoine F, Devynck MA, Palmblad J, Gyllenhammar H: Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. Blood 1999; 93:1399-405 (Pubitemid 29076156)
46. Dengiz GO, Odabasoglu F, Halici Z, Cadirci E, Suleyman H: Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J Pharmacol Sci 2007; 105:94-102 (Pubitemid 47469686)
47. Gideroglu K, Yilmaz F, Aksoy F, Bugdayci G, Saglam I, Yimaz F: Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury. J Surg Res 2009; 157:181-6